141 related articles for article (PubMed ID: 17269695)
1. Insights into the conformational changes of several human lysozyme variants associated with hereditary systemic amyloidosis.
Liu HL; Wu YC; Zhao JH; Liu YF; Huang CH; Fang HW; Ho Y
Biotechnol Prog; 2007; 23(1):246-54. PubMed ID: 17269695
[TBL] [Abstract][Full Text] [Related]
2. Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
Johnson RJ; Christodoulou J; Dumoulin M; Caddy GL; Alcocer MJ; Murtagh GJ; Kumita JR; Larsson G; Robinson CV; Archer DB; Luisi B; Dobson CM
J Mol Biol; 2005 Sep; 352(4):823-36. PubMed ID: 16126226
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of human lysozyme using molecular dynamics simulations.
Liu HL; Wu YC; Zhao JH; Fang HW; Ho Y
J Biomol Struct Dyn; 2006 Dec; 24(3):229-38. PubMed ID: 17054380
[TBL] [Abstract][Full Text] [Related]
4. Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure.
De Felice FG; Vieira MN; Meirelles MN; Morozova-Roche LA; Dobson CM; Ferreira ST
FASEB J; 2004 Jul; 18(10):1099-101. PubMed ID: 15155566
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants.
Canet D; Sunde M; Last AM; Miranker A; Spencer A; Robinson CV; Dobson CM
Biochemistry; 1999 May; 38(20):6419-27. PubMed ID: 10350460
[TBL] [Abstract][Full Text] [Related]
6. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.
Dumoulin M; Last AM; Desmyter A; Decanniere K; Canet D; Larsson G; Spencer A; Archer DB; Sasse J; Muyldermans S; Wyns L; Redfield C; Matagne A; Robinson CV; Dobson CM
Nature; 2003 Aug; 424(6950):783-8. PubMed ID: 12917687
[TBL] [Abstract][Full Text] [Related]
7. Simulations of human lysozyme: probing the conformations triggering amyloidosis.
Moraitakis G; Goodfellow JM
Biophys J; 2003 Apr; 84(4):2149-58. PubMed ID: 12668424
[TBL] [Abstract][Full Text] [Related]
8. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
[TBL] [Abstract][Full Text] [Related]
9. Unfolding of hen egg lysozyme by molecular dynamics simulations at 300K: insight into the role of the interdomain interface.
Gilquin B; Guilbert C; Perahia D
Proteins; 2000 Oct; 41(1):58-74. PubMed ID: 10944394
[TBL] [Abstract][Full Text] [Related]
10. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.
Booth DR; Sunde M; Bellotti V; Robinson CV; Hutchinson WL; Fraser PE; Hawkins PN; Dobson CM; Radford SE; Blake CC; Pepys MB
Nature; 1997 Feb; 385(6619):787-93. PubMed ID: 9039909
[TBL] [Abstract][Full Text] [Related]
11. A highly amyloidogenic region of hen lysozyme.
Frare E; Polverino De Laureto P; Zurdo J; Dobson CM; Fontana A
J Mol Biol; 2004 Jul; 340(5):1153-65. PubMed ID: 15236974
[TBL] [Abstract][Full Text] [Related]
12. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme.
Canet D; Last AM; Tito P; Sunde M; Spencer A; Archer DB; Redfield C; Robinson CV; Dobson CM
Nat Struct Biol; 2002 Apr; 9(4):308-15. PubMed ID: 11887182
[TBL] [Abstract][Full Text] [Related]
13. In silico prediction of novel residues involved in amyloid primary nucleation of human I56T and D67H lysozyme.
Griffin JWD; Bradshaw PC
BMC Struct Biol; 2018 Jul; 18(1):9. PubMed ID: 30029603
[TBL] [Abstract][Full Text] [Related]
14. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
Dumoulin M; Canet D; Last AM; Pardon E; Archer DB; Muyldermans S; Wyns L; Matagne A; Robinson CV; Redfield C; Dobson CM
J Mol Biol; 2005 Feb; 346(3):773-88. PubMed ID: 15713462
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the structure and dynamics of amyloidogenic variants of human lysozyme by NMR spectroscopy.
Chamberlain AK; Receveur V; Spencer A; Redfield C; Dobson CM
Protein Sci; 2001 Dec; 10(12):2525-30. PubMed ID: 11714920
[TBL] [Abstract][Full Text] [Related]
16. A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis.
Hagan CL; Johnson RJ; Dhulesia A; Dumoulin M; Dumont J; De Genst E; Christodoulou J; Robinson CV; Dobson CM; Kumita JR
Protein Eng Des Sel; 2010 Jul; 23(7):499-506. PubMed ID: 20382744
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the structural, dynamic and aggregation properties of the W64R amyloidogenic variant of human lysozyme.
Vettore N; Moray J; Brans A; Herman R; Charlier P; Kumita JR; Kerff F; Dobson CM; Dumoulin M
Biophys Chem; 2021 Apr; 271():106563. PubMed ID: 33640796
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations to determine the effect of supercritical carbon dioxide on the structural integrity of hen egg white lysozyme.
Liu HL; Hsieh WC; Liu HS
Biotechnol Prog; 2004; 20(3):930-8. PubMed ID: 15176901
[TBL] [Abstract][Full Text] [Related]
19. ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene.
Röcken C; Becker K; Fändrich M; Schroeckh V; Stix B; Rath T; Kähne T; Dierkes J; Roessner A; Albert FW
Hum Mutat; 2006 Jan; 27(1):119-20. PubMed ID: 16329101
[TBL] [Abstract][Full Text] [Related]
20. Human lysozyme gene mutations cause hereditary systemic amyloidosis.
Pepys MB; Hawkins PN; Booth DR; Vigushin DM; Tennent GA; Soutar AK; Totty N; Nguyen O; Blake CC; Terry CJ
Nature; 1993 Apr; 362(6420):553-7. PubMed ID: 8464497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
